Cargando…

Intravenous Immunoglobulin for Treatment of Severe Coronavirus Disease 19 (COVID-19) – A Literature Overview

Detalles Bibliográficos
Autores principales:	Rizvi, Syed, Kreuwel, Huub
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Mosby, Inc. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849592/ http://dx.doi.org/10.1016/j.jaci.2020.12.263

Ejemplares similares

Intravenous immunoglobulin immunotherapy for coronavirus disease‐19 (COVID‐19)
por: Galeotti, Caroline, et al.
Publicado: (2020)

Successful intravenous immunoglobulin treatment in severe COVID-19 pneumonia
por: Lanza, Maurizia, et al.
Publicado: (2020)

Intravenous immunoglobulins for treatment of severe COVID-19-related acute encephalopathy
por: Huo, Shufan, et al.
Publicado: (2022)

Treatment of a case of COVID-19 by intravenous immunoglobulin
por: Çolak, Mustafa, et al.
Publicado: (2021)

Intravenous immunoglobulin treatment for patients with severe COVID-19: a retrospective multicentre study
por: Liu, Jiao, et al.
Publicado: (2021)

Intravenous immunoglobulins (IVIG) in severe/critical COVID-19 adult patients
por: Kwapisz, Dorota, et al.
Publicado: (2023)

Combined intravenous immunoglobulin and baricitinib treatment for severe COVID-19 with rhabdomyolysis: A case report
por: Wu, Hao-Yu, et al.
Publicado: (2021)

Intravenous Immunoglobulin and Favipiravir treatment for A Kidney Transplant Patient with Severe Covid-19 Pneumonia
por: Tatar, Erhan, et al.
Publicado: (2020)

Intravenous immunoglobulin therapy for COVID-19 ARDS
por: Wilfong, Erin M, et al.
Publicado: (2022)

Effectiveness of intravenous immunoglobulin for children with severe COVID-19: a rapid review
por: Zhang, Jingyi, et al.
Publicado: (2020)

Overview of the pathogenesis and treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulins
por: Mahdi-Rogers, Mohamed, et al.
Publicado: (2010)

A single center experience of intravenous immunoglobulin treatment in Covid-19
por: Omma, Ahmet, et al.
Publicado: (2021)

Recovery of severely ill COVID-19 patients by intravenous immunoglobulin (IVIG) treatment: A case series
por: Mohtadi, Negar, et al.
Publicado: (2020)

Intravenous immunoglobulin as adjuvant therapy for COVID-19: A case report and literature review
por: Flores-Oria, Carlos A, et al.
Publicado: (2021)

Severe Coronavirus Disease 2019 That Recovered from Respiratory Failure by Treatment That Included High-dose Intravenous Immunoglobulin
por: Suzuki, Yasuhito, et al.
Publicado: (2020)

Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19
por: Xie, Yun, et al.
Publicado: (2020)

Intravenous immunoglobulin therapy in COVID-19-related encephalopathy
por: Muccioli, Lorenzo, et al.
Publicado: (2020)

Multimodality treatment in immunocompromised patients with severe COVID‐19: the role of IL‐6 inhibitor, intravenous immunoglobulin, and haemoperfusion
por: Leelayuwatanakul, Nophol, et al.
Publicado: (2021)

Severe Periodontal Disease Associated with Long-Term Treatment with Intravenous Immunoglobulin
por: Corrêa, Jôice Dias, et al.
Publicado: (2014)

Intravenous Immunoglobulin in the Treatment of Severe Clostridium Difficile Colitis
por: Shah, Nihar, et al.
Publicado: (2014)

Intravenous immunoglobulin for the treatment of Kawasaki disease
por: Broderick, Cathryn, et al.
Publicado: (2023)

High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China
por: Cao, Wei, et al.
Publicado: (2021)

Long-term efficacy, safety, and tolerability of a subcutaneous immunoglobulin 16.5% (cutaquig(®)) in the treatment of patients with primary immunodeficiencies
por: Kobayashi, Roger H, et al.
Publicado: (2022)

Potential therapeutic approach of intravenous immunoglobulin against COVID-19
por: Kolahchi, Zahra, et al.
Publicado: (2021)

Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease
por: Danieli, Maria Giovanna, et al.
Publicado: (2021)

Case Series of Successful Intravenous Immunoglobulin (IVIG) Treatment in 4 Pregnant Patients with Severe COVID-19-Induced Hypoxia
por: Geriak, Matthew, et al.
Publicado: (2022)

What's new in critical illness and injury science? Intravenous immunoglobulin for COVID-19 with severe or critical illness
por: Miller, Andrew C., et al.
Publicado: (2020)

Efficacy of high-dose intravenous immunoglobulin in severe and critical COVID-19: A retrospective cohort study
por: Aggarwal, Ritesh, et al.
Publicado: (2022)

Corrigendum: High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China
por: Cao, Wei, et al.
Publicado: (2021)

Intravenous immunoglobulin in COVID-19 associated Guillain–Barré syndrome in pregnancy
por: Garcia, Jao Jarro, et al.
Publicado: (2021)

Post–COVID‐19 Myoclonus–Ataxia Syndrome Responsive to Intravenous Immunoglobulins
por: Godani, Massimiliano, et al.
Publicado: (2022)

Intravenous Immunoglobulin Plus Methylprednisolone Mitigate Respiratory Morbidity in Coronavirus Disease 2019
por: Sakoulas, George, et al.
Publicado: (2020)

The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial
por: Gharebaghi, Naser, et al.
Publicado: (2020)

Intravenous Immunoglobulin-Associated Severe Hemolytic Anemia
por: KC, Ojbindra, et al.
Publicado: (2023)

Intravenous immunoglobulins for the treatment of the hyper-inflammatory response in COVID-19. Another failure of immunomodulatory therapy?
por: López-Medrano, Francisco, et al.
Publicado: (2021)

Intravenous pulse methylprednisolone for the treatment of severe COVID-19
por: Patoulias, Dimitrios, et al.
Publicado: (2023)

Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial
por: Tabarsi, Payam, et al.
Publicado: (2021)

Intravenous immunoglobulin-based adjuvant therapy for severe COVID-19: a single-center retrospective cohort study
por: Hou, Xiao, et al.
Publicado: (2021)

Case report: A case of severe retropharyngeal edema after COVID-19 successfully treated with intravenous immunoglobulin
por: Suzuki, Takanori, et al.
Publicado: (2023)

Coronavirus disease (COVID-19) pandemic: an overview of systematic reviews
por: Borges do Nascimento, Israel Júnior, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_njekmjedk72u5oirop94ai8833